Apiject has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements of the drug product.
March 1, 2024
Test Drive Our Technology
Might interest you
View All
BFS Technology
The Apiject Platform: Transforming Drug Delivery
We did not just create a platform for prefilled drug delivery. We also developed the necessary technologies to make this platform practical for pharma companies to adopt. This includes enhanced temperature management of the drug product throughout the filling process, high-speed visual...
Global Health
Delivering Every Dose Better: Frontline Interviews
These frontline interviews and user testing sessions are invaluable sources of feedback that allow our engineers to design and manufacture modifications to better serve these constituencies’ needs
Global Health
ApiJect Systems Receives Grant to Develop Low-Cost Blow-Fill-Seal Prefilled Injection Device for Low- and Middle-Income Countries
Grant will fund the design and development of an affordable, multi-month contraceptive delivery device to enhance access in Low- and Middle-Income Countries (LMICs). Blow-Fill-Seal will be explored for the container closure and subcutaneous injection delivery system, advancing a concept initially developed by...